Hims Hers Health Inc annual ebitda for fiscal TTM was -$76 million, compared with $178 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EBITDA (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| EBITDA | ($76M) | $178M | $89M | ($12M) | ($58M) | ($107M) | ($14M) | ($71M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EBITDA (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| EBITDA | ($63M) | ($80M) | $36M | $30M | $43M | $69M | $28M | $28M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More HIMS metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding
All HIMS financial statements → Interactive HIMS charts →
About TickerBase · Data methodology & sources · Privacy · Terms